Treatment Timing Impacts Survival in Limited Stage Small Cell Lung Cancer

Miriam Grønberg, a medical student from the University of Bergen, Norway, presented a poster at ELCC 2025 on a study examining how treatment timing affects survival in limited-stage small cell lung cancer. The findings highlight that starting thoracic radiotherapy soon after chemotherapy is linked to better survival, underscoring the importance of timely treatment.